+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)



Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)



Bmj 306(6870): 107-108




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046078978

Download citation: RISBibTeXText

PMID: 8435602

DOI: 10.1136/bmj.306.6870.107


Related references

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 30(1): 277-282, 1999

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 30(1): 238-243, 1999

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 26(5): 1338-1342, 1997

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 30(3): 801-807, 1999

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP). American Journal of Gastroenterology 93(6): 896-900, 1998

Eurohep. A European Community sponsored concerted action on viral hepatitis: its rationale and execution. Journal of Hepatology 15(1-2): 1-3, 1992

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). Journal of Hepatology 21(4): 656-666, 1994

Fatal hepatic decompensation associated with interferon alfa. British Medical Journal 306(6870): 107-108, 1993

The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment. Journal of Viral Hepatitis 5(6): 389-397, 1998

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 21(1): 77-82, 1995

Combination of low-dose ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic hepatitis C virus-infected non-responders and relapsers after interferon alfa-2a monotherapy. Hepatology 32(4 Pt 2): 353A, 2000

General report on the European Union Concerted Action Workshop on 11q23, London, UK; May 1997; (European Concerted Action for Molecular and Cytogenic Studies and The Kay Kendall Leukaemia Fund). Leukemia 12(5): 776-778, 1998

Fatal hepatic decompensation in a patient with hepatitis B cirrhosis following famciclovir withdrawal. Canadian Journal of Gastroenterology 14(8): 725-727, 2000

Interferon alfa 2b and Ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon monotherapy. Hepatology 30(4 Part 2): 624A, 1999

Interferon dose increase for early non-responders to interferon alfa-2b+ribavirin therapy for chronic hepatitis C does not lead to a viral response at 48 weeks. Hepatology 34(4 Pt 2): 598A, 2001